Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Drugs
used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Combining vaccine therapy with chemotherapy may kill more tumor cells.
PURPOSE: Randomized phase II trial to compare the effectiveness of vaccine therapy with or
without docetaxel in treating patients who have metastatic prostate cancer.